Dr David Tan
graduated in 2001 with an intercalated BSc in Experimental Pathology (1st Class Honours) and MBBS with Distinction from Guy’s, King’s and St Thomas’ School of Medicine, University of London, UK. He undertook training in internal medicine at Hammersmith Hospital and Guy’s and St Thomas’ Hospitals in London, and obtained his MRCP (UK) in 2005. In that same year, he was awarded a Cancer Research UK (CRUK) Clinical Research Fellowship and conducted research in ovarian and breast cancer from 2005 to 2008 with Professor Stan Kaye at The Institute of Cancer Research (the academic partner institution of The Royal Marsden Hospital), London, where he obtained his PhD. He completed his specialist training in medical oncology at The Royal Marsden Hospital, London, UK from 2008 to 2012, and was awarded his Certificate of Completion of Training (CCT) in Medical Oncology and MRCP (UK) (Medical Oncology).
After working in the Drug Development Unit at The Royal Marsden Hospital/Institute of Cancer Research, he went on to complete another fellowship at the Princess Margaret Cancer Centre, University of Toronto, Canada, in Drug Development and Gynaecologic Oncology from 2012 to 2013 before returning to Singapore. Dr Tan currently practises as a consultant medical oncologist and clinician scientist at the National University Cancer Institute, Singapore. He is also an Assistant Professor in the Department of Medicine at the Yong Loo Lin School of Medicine, National University of Singapore.
His primary clinical and research interests are in gynaecological (ovarian, endometrial and cervical) cancers, genomic cancer medicine, and the development of novel anti-cancer therapeutic agents. He has authored over 50 peer-reviewed scientific papers and abstracts and received several awards for his research as well.